COVID-19 Antibody Study in Ethiopian Healthcare Workers
Part of Infections, Lungs & breathing clinical trials.
This study looks at how antibodies from a past COVID-19 infection protect healthcare workers in Ethiopia from getting sick again. Participants will give blood samples and report any COVID-19 symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You work in a hospital (like a doctor, nurse, student, cleaner, or other hospital staff).
- You are willing to give blood samples for testing.
- You can share your health information and get a nasal swab test if you have COVID-19 symptoms.
- You are not a prisoner or have a serious mental illness, and study participation would not be risky for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects extra blood or other samples from people who are already getting routine COVID-19 tests or monitoring. The samples are used to better understand how the virus affects the body and to improve future testing.
This study measures how many healthcare workers have COVID antibodies (proof of past infection or immune response). Results may help estimate how widespread COVID exposure has been among hospital staff.
This study gathers information about healthcare workers (adults) and tracks your past COVID-19 infection and vaccination history. It may help researchers understand how COVID affects healthcare workers and how vaccines relate to infection outcomes.
This study looks at how the immune system responds to COVID-19 in healthcare workers and infected patients at Danderyd Hospital. It aims to understand immunity and help guide future care.
This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.
This study looks at how the immune system in the body responds to different COVID-19 virus variants. It may help improve how COVID-19 is diagnosed by comparing people who are currently infected and those who are not.
Hear when a new SARS CoV 2 Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.